XML 35 R23.htm IDEA: XBRL DOCUMENT
v3.25.1

Concentration of risk | 9 Months Ended
--- | ---
Mar. 31, 2025
Risks and Uncertainties [Abstract] |
Concentration of risk | Note 16 - Concentration of risk Credit risk Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash and cash equivalents and accounts receivable. As of March 31, 2025 and June 30, 2024, $2,192,255 and $7,377,837, respectively, were deposited with various major financial institutions in the United States and PRC. Accounts at each institution in the United States are insured by the Federal Deposit Insurance Corporation (FDIC) for up to $250,000. The Company had approximately $1.4 million and $5.8 million, respectively, in excess of the FDIC insurance limit, as of March 31, 2025 and June 30, 2024. Accounts receivable are typically unsecured and derived from revenue earned from customers, thereby exposing the Company to credit risk. The risk is mitigated by the Company’s assessment of its customers’ creditworthiness and its ongoing monitoring of outstanding balances. The Company maintains reserves for estimated credit losses, and such losses have generally been within expectations. The business of DHS, the Company’s VIE, may be impacted by Chinese economic conditions, changes in regulations and laws, and other uncertainties. Customer and vendor concentration risk For the nine months ended March 31, 2025 and 2024, Amazon Vendor and Amazon Seller customers accounted for 85% and 91% of the Company's total revenues, respectively. As of March 31, 2025 and June 30, 2024, accounts receivable from Amazon Vendor and Amazon Seller accounted for 84% and 91% of the Company’s total accounts receivable. For the nine months ended March 31, 2025 and 2024, one supplier accounted for 12% and 10% of the Company's total purchases, respectively. As of March 31, 2025 and June 30, 2024, accounts payable to two suppliers accounted for 19% (9% and 9%) and 45% (36% and 9%) of the Company’s total accounts payable.

X
- Definition The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 275 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/275/tableOfContent + Details
Name: | us-gaap_ConcentrationRiskDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_RisksAndUncertaintiesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration